1. Henson MC, Chedrese PJ. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp Biol Med (Maywood). 2004; 229:383–392.
2. Kumar A, Scott Clark C. Lead loadings in household dust in Delhi, India. Indoor Air. 2009; 19:414–420.
3. Rosin A. The long-term consequences of exposure to lead. Isr Med Assoc J. 2009; 11:689–694.
4. Mercier M. International approach of the assessment of chemical risks. J Hyg Epidemiol Microbiol Immunol. 1990; 34:1–7.
5. Nogawa K, Kido T. Biological monitoring of cadmium exposure in itai-itai disease epidemiology. Int Arch Occup Environ Health. 1993; 65:S43–S46.
6. Harada M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol. 1995; 25:1–24.
7. Vig EK, Hu H. Lead toxicity in older adults. J Am Geriatr Soc. 2000; 48:1501–1506.
8. Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011; 283:65–87.
9. Engström A, Michaëlsson K, Vahter M, et al. Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and fractures among women. Bone. 2012; 50:1372–1378.
10. Jin GB, Inoue S, Urano T, et al. Induction of anti-metallothionein antibody and mercury treatment decreases bone mineral density in mice. Toxicol Appl Pharmacol. 2002; 185:98–110.
11. Klein RF, Wiren KM. Regulation of osteoblastic gene expression by lead. Endocrinology. 1993; 132:2531–2537.
12. Suzuki H, Asakawa A, Li JB, et al. Zinc as an appetite stimulator - the possible role of zinc in the progression of diseases such as cachexia and sarcopenia. Recent Pat Food Nutr Agric. 2011; 3:226–231.
13. Wallin M, Barregard L, Sallsten G, et al. Low-level cadmium exposure is associated with decreased bone mineral density and increased risk of incident fractures in elderly men: the MrOS Sweden study. J Bone Miner Res. 2016; 31:732–741.
14. Vanitallie TB. Frailty in the elderly: contributions of sarcopenia and visceral protein depletion. Metabolism. 2003; 52:22–26.
15. Lloyd BD, Williamson DA, Singh NA, et al. Recurrent and injurious falls in the year following hip fracture: a prospective study of incidence and risk factors from the Sarcopenia and Hip Fracture study. J Gerontol A Biol Sci Med Sci. 2009; 64:599–609.
16. Yoon HK, Park C, Jang S, et al. Incidence and mortality following hip fracture in Korea. J Korean Med Sci. 2011; 26:1087–1092.
17. Frisoli A Jr, Chaves PH, Ingham SJ, et al. Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Womens Health and Aging Study (WHAS) II. Bone. 2011; 48:952–957.
18. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15:95–101.
19. Kwon HJ, Ha YC, Park HM. Prevalence of sarcopenia in the Korean woman based on the Korean national health and nutritional examination surveys. J Bone Metab. 2016; 23:23–26.
20. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997; 127:990s–991s.
21. Kaji H. Interaction between muscle and bone. J Bone Metab. 2014; 21:29–40.
22. Patil R, Uusi-Rasi K, Pasanen M, et al. Sarcopenia and osteopenia among 70-80-year-old home-dwelling Finnish women: prevalence and association with functional performance. Osteoporos Int. 2013; 24:787–796.
23. Verschueren S, Gielen E, O'Neill TW, et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int. 2013; 24:87–98.
24. Alfvén T, Järup L, Elinder CG. Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. Environ Health Perspect. 2002; 110:699–702.
25. Barry PS. A comparison of concentrations of lead in human tissues. Br J Ind Med. 1975; 32:119–139.
26. Hamilton JD, O'Flaherty EJ. Effects of lead exposure on skeletal development in rats. Fundam Appl Toxicol. 1994; 22:594–604.
27. Goyer RA, Epstein S, Bhattacharyya M, et al. Environmental risk factors for osteoporosis. Environ Health Perspect. 1994; 102:390–394.
28. Escribano A, Revilla M, Hernández ER, et al. Effect of lead on bone development and bone mass: a morphometric, densitometric, and histomorphometric study in growing rats. Calcif Tissue Int. 1997; 60:200–203.
29. Potula V, Kleinbaum D, Kaye W. Lead exposure and spine bone mineral density. J Occup Environ Med. 2006; 48:556–564.
30. Campbell JR, Auinger P. The association between blood lead levels and osteoporosis among adults--results from the third national health and nutrition examination survey (NHANES III). Environ Health Perspect. 2007; 115:1018–1022.
31. Ma Y, Fu D, Liu Z. Effect of lead on apoptosis in cultured rat primary osteoblasts. Toxicol Ind Health. 2012; 28:136–146.
32. Pounds JG, Long GJ, Rosen JF. Cellular and molecular toxicity of lead in bone. Environ Health Perspect. 1991; 91:17–32.
33. Puzas JE, Sickel MJ, Felter ME. Osteoblasts and chondrocytes are important target cells for the toxic effects of lead. Neurotoxicology. 1992; 13:783–788.
34. Suzuki N, Yamamoto M, Watanabe K, et al. Both mercury and cadmium directly influence calcium homeostasis resulting from the suppression of scale bone cells: the scale is a good model for the evaluation of heavy metals in bone metabolism. J Bone Miner Metab. 2004; 22:439–446.
35. Cho GJ, Park HT, Shin JH, et al. The relationship between blood mercury level and osteoporosis in postmenopausal women. Menopause. 2012; 19:576–581.
36. Chen X, Wang K, Wang Z, et al. Effects of lead and cadmium co-exposure on bone mineral density in a Chinese population. Bone. 2014; 63:76–80.